메뉴 건너뛰기




Volumn 13, Issue 1, 2013, Pages 26-54

Allosteric modulators for the treatment of schizophrenia: Targeting glutamatergic networks

Author keywords

Allosterism; AMPA; Glutamate; Glycine; NAMS; NMDA; PAMS; Schizophrenia

Indexed keywords

2 CHLORO N [ALPHA (2 PIPERIDINYL) BENZYL] 3 TRIFLUOROMETHYLBENZAMIDE; 2 CHLORO N [ALPHA (2 PIPERIDINYL)BENZYL] 3 TRIFLUOROMETHYLBENZAMIDE; 2, 3 DIHYDRO 3, 4 CYCLOPENTANO 1, 2, 4 BENZOTHIADIAZINE 1, 1 DIOXIDE; 2,3 DIHYDRO 3,4 CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR; BITOPERTIN; CLOZAPINE; CYCLOSERINE; CYCLOTHIAZIDE; DEXTRO ALANINE; DOPAMINE; FARAMPATOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR LIGAND; GLYCINE; GLYCINE TRANSPORTER 1; HALOPERIDOL; LIGAND; LY 2365109; METABOTROPIC RECEPTOR; N [2 [4 (4 CYANOPHENYL) PHENYL] PROPYL] 2 PROPANESULFONAMIDE; N [3 (4 FLUOROPHENYL) 3 (4 PHENYLPHENOXY) PROPYL] SARCOSINE; N [3 (4 FLUOROPHENYL) 3 (4 PHENYLPHENOXY)PROPYL]SARCOSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; PIRACETAM; PLACEBO; SERINE; UNCLASSIFIED DRUG;

EID: 84876720539     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313010005     Document Type: Review
Times cited : (74)

References (255)
  • 1
    • 2942648152 scopus 로고    scopus 로고
    • Schizophrenia
    • Mueser, K.; McGurk, S. Schizophrenia. The Lancet, 2004, 363, 2063-2072.
    • (2004) The Lancet , vol.363 , pp. 2063-2072
    • Mueser, K.1    McGurk, S.2
  • 2
    • 67650130341 scopus 로고    scopus 로고
    • When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia
    • Javitt, D. C. When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia. Annu. Rev. Clin. Psychol., 2009, 5, 249-275.
    • (2009) Annu. Rev. Clin. Psychol , vol.5 , pp. 249-275
    • Javitt, D.C.1
  • 3
    • 18744366088 scopus 로고    scopus 로고
    • Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review
    • Newcomer, J. W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS drugs, 2005, 19 Suppl 1, 1-93.
    • (2005) CNS Drugs , vol.19 , Issue.SUPPL. 1 , pp. 1-93
    • Newcomer, J.W.1
  • 4
    • 0029918481 scopus 로고    scopus 로고
    • What are the functional consequences of neurocognitive deficits in schizophrenia?
    • Green, M. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry, 1996, 153, 321-330.
    • (1996) Am. J. Psychiatry , vol.153 , pp. 321-330
    • Green, M.1
  • 6
    • 0034843738 scopus 로고    scopus 로고
    • The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
    • Goff, D. C.; Coyle, J. T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry, 2001, 158, 1367-1377.
    • (2001) Am. J. Psychiatry , vol.158 , pp. 1367-1377
    • Goff, D.C.1    Coyle, J.T.2
  • 10
    • 0345830631 scopus 로고    scopus 로고
    • Physiological roles and therapeutic potential of metabotropic glutamate receptors
    • Conn, P. J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N Y Acad. Sci., 2003, 1003, 12-21.
    • (2003) Ann. N Y Acad. Sci , vol.1003 , pp. 12-21
    • Conn, P.J.1
  • 11
    • 17744387125 scopus 로고    scopus 로고
    • Ionotropic and metabotropic glutamate receptor structure and pharmacology
    • Kew, J. N. C.; Kemp, J. A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology, 2005, 179, 4-29.
    • (2005) Psychopharmacology , vol.179 , pp. 4-29
    • Kew, J.N.C.1    Kemp, J.A.2
  • 12
    • 0142095005 scopus 로고    scopus 로고
    • NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: Toward a paradigm shift in medication development
    • Krystal, J. H.; D'Souza, D. C.; Mathalon, D.; Perry, E.; Belger, A.; Hoffman, R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology, 2003, 169, 215-233.
    • (2003) Psychopharmacology , vol.169 , pp. 215-233
    • Krystal, J.H.1    D'Souza, D.C.2    Mathalon, D.3    Perry, E.4    Belger, A.5    Hoffman, R.6
  • 13
    • 0032694066 scopus 로고    scopus 로고
    • NMDA receptor hypofunction model of schizophrenia
    • Olney, J. W.; Newcomer, J. W.; Farber, N. B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res., 1999, 33, 523-533.
    • (1999) J. Psychiatr. Res , vol.33 , pp. 523-533
    • Olney, J.W.1    Newcomer, J.W.2    Farber, N.B.3
  • 14
    • 79955745328 scopus 로고    scopus 로고
    • Glutamate: New hope for schizophrenia therapy
    • Kantrowitz, E. R.; Javitt, D. Glutamate: New hope for schizophrenia therapy. Current Psychiatry, 2011, 10, 69-74.
    • (2011) Current Psychiatry , vol.10 , pp. 69-74
    • Kantrowitz, E.R.1    Javitt, D.2
  • 15
    • 84855927044 scopus 로고    scopus 로고
    • Targeting glutamate synapses in schizophrenia
    • Field, J. R.; Walker, A. G.; Conn, P. J. Targeting glutamate synapses in schizophrenia. Trends Mol. Med., 2011, 17, 689-698.
    • (2011) Trends Mol. Med , vol.17 , pp. 689-698
    • Field, J.R.1    Walker, A.G.2    Conn, P.J.3
  • 16
    • 84870064466 scopus 로고    scopus 로고
    • Neurodevelopmental model of schizophrenia: Update 2012
    • Rapoport, J. L.; Giedd, J. N.; Gogtay, N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry, 2012, 17, 1228-1238.
    • (2012) Mol. Psychiatry , vol.17 , pp. 1228-1238
    • Rapoport, J.L.1    Giedd, J.N.2    Gogtay, N.3
  • 19
    • 33748474553 scopus 로고    scopus 로고
    • Pathophysiologically based treatment interventions in schizophrenia
    • Lewis, D. A.; Gonzalez-Burgos, G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med., 2006, 12, 1016-1022.
    • (2006) Nat. Med , vol.12 , pp. 1016-1022
    • Lewis, D.A.1    Gonzalez-Burgos, G.2
  • 20
    • 16344372645 scopus 로고    scopus 로고
    • Cortical inhibitory neurons and schizophrenia
    • Lewis, D. A.; Hashimoto, T.; Volk, D. W. Cortical inhibitory neurons and schizophrenia. Nat. Rev.Neurosci., 2005, 6, 312-324.
    • (2005) Nat. Rev.Neurosci , vol.6 , pp. 312-324
    • Lewis, D.A.1    Hashimoto, T.2    Volk, D.W.3
  • 21
    • 84856857477 scopus 로고    scopus 로고
    • Cortical basket cell dysfunction in schizophrenia
    • Curley, A. A.; Lewis, D. A. Cortical basket cell dysfunction in schizophrenia. J. Physiol., 2012, 590, 715-724.
    • (2012) J. Physiol , vol.590 , pp. 715-724
    • Curley, A.A.1    Lewis, D.A.2
  • 22
    • 80051782825 scopus 로고    scopus 로고
    • Selective Pyramidal Cell Reduction of GABA(A) Receptor alpha1 Subunit Messenger RNA Expression in Schizophrenia
    • Glausier, J. R.; Lewis, D. A. Selective Pyramidal Cell Reduction of GABA(A) Receptor alpha1 Subunit Messenger RNA Expression in Schizophrenia. Neuropsychopharmacology, 2011, 36, 2103-2110.
    • (2011) Neuropsychopharmacology , vol.36 , pp. 2103-2110
    • Glausier, J.R.1    Lewis, D.A.2
  • 23
    • 84863201711 scopus 로고    scopus 로고
    • NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons and Cortical Gamma Oscillations in Schizophrenia
    • Gonzalez-Burgos, G.; Lewis, D. A. NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons and Cortical Gamma Oscillations in Schizophrenia. Schizophr. Bull., 2012, 38, 950-957.
    • (2012) Schizophr. Bull , vol.38 , pp. 950-957
    • Gonzalez-Burgos, G.1    Lewis, D.A.2
  • 24
    • 77950669072 scopus 로고    scopus 로고
    • Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia
    • Torkamani, A.; Dean, B.; Schork, N. J.; Thomas, E. A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res., 2010, 20, 403-412.
    • (2010) Genome Res , vol.20 , pp. 403-412
    • Torkamani, A.1    Dean, B.2    Schork, N.J.3    Thomas, E.A.4
  • 26
    • 77955621530 scopus 로고    scopus 로고
    • Genes and environment: Multiple pathways to psychopathology
    • Mann, J. J.; Haghighi, F. Genes and environment: multiple pathways to psychopathology. Biol. Psychiatry, 2010, 68, 403-404.
    • (2010) Biol. Psychiatry , vol.68 , pp. 403-404
    • Mann, J.J.1    Haghighi, F.2
  • 27
    • 0033956237 scopus 로고    scopus 로고
    • Schizophrenia: Genes and environment
    • Tsuang, M. Schizophrenia: genes and environment. Biol. Psychiatry, 2000, 47, 210-220.
    • (2000) Biol. Psychiatry , vol.47 , pp. 210-220
    • Tsuang, M.1
  • 28
    • 84856706805 scopus 로고    scopus 로고
    • Puzzling over schizophrenia: Schizophrenia as a pathway disease
    • Sullivan, P. F. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat. Med., 2012, 18, 210-211.
    • (2012) Nat. Med , vol.18 , pp. 210-211
    • Sullivan, P.F.1
  • 32
    • 77951636682 scopus 로고    scopus 로고
    • Gene-and evidence-based candidate gene selection for schizophrenia and gene feature analysis
    • Sun, J.; Han, L.; Zhao, Z. Gene-and evidence-based candidate gene selection for schizophrenia and gene feature analysis. Artif. Intell. Med., 2010, 48, 99-106.
    • (2010) Artif. Intell. Med , vol.48 , pp. 99-106
    • Sun, J.1    Han, L.2    Zhao, Z.3
  • 33
    • 70349884348 scopus 로고    scopus 로고
    • A multidimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case
    • Sun, J.; Jia, P.; Fanous, A. H.; Webb, B. T.; van den Oord, E. J.; Chen, X.; Bukszar, J.; Kendler, K. S.; Zhao, Z. A multidimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics, 2009, 25, 2595-6602.
    • (2009) Bioinformatics , vol.25 , pp. 2595-6602
    • Sun, J.1    Jia, P.2    Fanous, A.H.3    Webb, B.T.4    van den Oord, E.J.5    Chen, X.6    Bukszar, J.7    Kendler, K.S.8    Zhao, Z.9
  • 34
    • 77949540980 scopus 로고    scopus 로고
    • SZGR: A comprehensive schizophrenia gene resource
    • Jia, P.; Sun, J.; Guo, A. Y.; Zhao, Z. SZGR: a comprehensive schizophrenia gene resource. Mol. Psychiatry, 2010, 15, 453-462.
    • (2010) Mol. Psychiatry , vol.15 , pp. 453-462
    • Jia, P.1    Sun, J.2    Guo, A.Y.3    Zhao, Z.4
  • 35
    • 84555189458 scopus 로고    scopus 로고
    • An integrative functional genomics approach for discovering biomarkers in schizophrenia
    • Vawter, M. P.; Mamdani, F.; Macciardi, F. An integrative functional genomics approach for discovering biomarkers in schizophrenia. Brief Funct. Genomics, 2011, 10, 387-399.
    • (2011) Brief Funct. Genomics , vol.10 , pp. 387-399
    • Vawter, M.P.1    Mamdani, F.2    Macciardi, F.3
  • 37
    • 84864033725 scopus 로고    scopus 로고
    • Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression
    • Lee, S. A.; Tsao, T. T.; Yang, K. C.; Lin, H.; Kuo, Y. L.; Hsu, C. H.; Lee, W. K.; Huang, K. C.; Kao, C. Y. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics, 2011, 12 Suppl 13, S20.
    • (2011) BMC Bioinformatics , vol.12 , Issue.SUPPL. 13
    • Lee, S.A.1    Tsao, T.T.2    Yang, K.C.3    Lin, H.4    Kuo, Y.L.5    Hsu, C.H.6    Lee, W.K.7    Huang, K.C.8    Kao, C.Y.9
  • 39
    • 80053131124 scopus 로고    scopus 로고
    • Large-scale brain networks and psychopathology: A unifying triple network model
    • Menon, V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn. Sci., 2011, 15, 483-506.
    • (2011) Trends Cogn. Sci , vol.15 , pp. 483-506
    • Menon, V.1
  • 40
    • 79952680751 scopus 로고    scopus 로고
    • Dysfunctional brain networks and genetic risk for schizophrenia: Specific neurotransmitter systems
    • Hirvonen, J.; Hietala, J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS Neurosci. Ther., 2011, 17, 89-96.
    • (2011) CNS Neurosci. Ther , vol.17 , pp. 89-96
    • Hirvonen, J.1    Hietala, J.2
  • 41
    • 78649906486 scopus 로고    scopus 로고
    • Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia
    • Balu, D. T.; Coyle, J. T. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci. Biobehav. Rev., 2011, 35, 848-870.
    • (2011) Neurosci. Biobehav. Rev , vol.35 , pp. 848-870
    • Balu, D.T.1    Coyle, J.T.2
  • 42
    • 77956647781 scopus 로고    scopus 로고
    • The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
    • Buonanno, A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res. Bull., 2010, 83, 122-131.
    • (2010) Brain Res. Bull , vol.83 , pp. 122-131
    • Buonanno, A.1
  • 43
    • 77956648156 scopus 로고    scopus 로고
    • N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
    • Kantrowitz, J. T.; Javitt, D. C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull., 2010, 83, 108-121.
    • (2010) Brain Res. Bull , vol.83 , pp. 108-121
    • Kantrowitz, J.T.1    Javitt, D.C.2
  • 44
  • 45
    • 0030749913 scopus 로고    scopus 로고
    • Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
    • Malhotra, A. K.; Pinals, D. A.; Adler, C. M.; Elman, I.; Clifton, A.; Pickar, D.; Breier, A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology, 1997, 17, 141-150.
    • (1997) Neuropsychopharmacology , vol.17 , pp. 141-150
    • Malhotra, A.K.1    Pinals, D.A.2    Adler, C.M.3    Elman, I.4    Clifton, A.5    Pickar, D.6    Breier, A.7
  • 46
    • 84866640784 scopus 로고    scopus 로고
    • Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
    • Domino, E. F.; Luby, E. D. Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future. Schizophr. Bull., 2012, 38, 914-919.
    • (2012) Schizophr. Bull , vol.38 , pp. 914-919
    • Domino, E.F.1    Luby, E.D.2
  • 47
    • 30844439634 scopus 로고    scopus 로고
    • Glutamate-based therapeutic approaches: Clinical trials with NMDA antagonists
    • Muir, K. W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol., 2006, 6, 53-60.
    • (2006) Curr. Opin. Pharmacol , vol.6 , pp. 53-60
    • Muir, K.W.1
  • 48
    • 0032824132 scopus 로고    scopus 로고
    • Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke
    • Dyker, A. G.; Edwards, K. R.; Fayad, P. B.; Hormes, J. T.; Lees, K. R. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke. Stroke, 1999, 30, 2038-2042.
    • (1999) Stroke , vol.30 , pp. 2038-2042
    • Dyker, A.G.1    Edwards, K.R.2    Fayad, P.B.3    Hormes, J.T.4    Lees, K.R.5
  • 49
    • 0029555515 scopus 로고
    • Clinical pharmacology of CNS 1102 in volunteers
    • discussion 298
    • Muir, K. W.; Grosset, D. G.; Lees, K. R. Clinical pharmacology of CNS 1102 in volunteers. Ann. N Y Acad. Sci., 1995, 765, 279-289; discussion 298.
    • (1995) Ann. N Y Acad. Sci , vol.765 , pp. 279-289
    • Muir, K.W.1    Grosset, D.G.2    Lees, K.R.3
  • 50
    • 0141836222 scopus 로고    scopus 로고
    • Excitatory amino acid antagonists for acute stroke
    • Muir, K. W.; Lees, K. R. Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst. Rev., 2003, CD001244.
    • (2003) Cochrane Database Syst. Rev
    • Muir, K.W.1    Lees, K.R.2
  • 51
    • 0032103160 scopus 로고    scopus 로고
    • Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers
    • Adler, C. M.; Goldberg, T. E.; Malhotra, A. K.; Pickar, D.; Breier, A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol. Psychiatry, 1998, 43, 811-816.
    • (1998) Biol. Psychiatry , vol.43 , pp. 811-816
    • Adler, C.M.1    Goldberg, T.E.2    Malhotra, A.K.3    Pickar, D.4    Breier, A.5
  • 52
    • 0032859516 scopus 로고    scopus 로고
    • Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia
    • Adler, C. M.; Malhotra, A. K.; Elman, I.; Goldberg, T.; Egan, M.; Pickar, D.; Breier, A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry, 1999, 156, 1646-1649.
    • (1999) Am. J. Psychiatry , vol.156 , pp. 1646-1649
    • Adler, C.M.1    Malhotra, A.K.2    Elman, I.3    Goldberg, T.4    Egan, M.5    Pickar, D.6    Breier, A.7
  • 53
    • 0030966452 scopus 로고    scopus 로고
    • Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
    • Breier, A.; Malhotra, A. K.; Pinals, D. A.; Weisenfeld, N. I.; Pickar, D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry, 1997, 154, 805-811.
    • (1997) Am. J. Psychiatry , vol.154 , pp. 805-811
    • Breier, A.1    Malhotra, A.K.2    Pinals, D.A.3    Weisenfeld, N.I.4    Pickar, D.5
  • 57
    • 30944451560 scopus 로고    scopus 로고
    • The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia
    • Honey, G. D.; O'Loughlin, C.; Turner, D. C.; Pomarol-Clotet, E.; Corlett, P. R.; Fletcher, P. C. The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia. Neuropsychopharmacology, 2005, 31, 413-423.
    • (2005) Neuropsychopharmacology , vol.31 , pp. 413-423
    • Honey, G.D.1    O'Loughlin, C.2    Turner, D.C.3    Pomarol-Clotet, E.4    Corlett, P.R.5    Fletcher, P.C.6
  • 58
    • 84866674097 scopus 로고    scopus 로고
    • Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
    • Javitt, D. C.; Zukin, S. R.; Heresco-Levy, U.; Umbricht, D. Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia. Schizophr. Bull., 2012, 38, 958-966.
    • (2012) Schizophr. Bull , vol.38 , pp. 958-966
    • Javitt, D.C.1    Zukin, S.R.2    Heresco-Levy, U.3    Umbricht, D.4
  • 59
    • 73949124536 scopus 로고    scopus 로고
    • Sensory processing in schizophrenia: Neither simple nor intact
    • Javitt, D. C. Sensory processing in schizophrenia: neither simple nor intact. Schizophr. Bull., 2009, 35, 1059-1064.
    • (2009) Schizophr. Bull , vol.35 , pp. 1059-1064
    • Javitt, D.C.1
  • 60
    • 77149138329 scopus 로고    scopus 로고
    • Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain
    • Marek, G. J.; Behl, B.; Bespalov, A. Y.; Gross, G.; Lee, Y.; Schoemaker, H. Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain? Mol. Pharmacol., 2009, 77, 317-326.
    • (2009) Mol. Pharmacol , vol.77 , pp. 317-326
    • Marek, G.J.1    Behl, B.2    Bespalov, A.Y.3    Gross, G.4    Lee, Y.5    Schoemaker, H.6
  • 61
    • 0034600485 scopus 로고    scopus 로고
    • Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. GAIN International Investigators
    • Lees, K. R.; Asplund, K.; Carolei, A.; Davis, S. M.; Diener, H. C.; Kaste, M.; Orgogozo, J. M.; Whitehead, J. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet, 2000, 355, 1949-1954.
    • (2000) Lancet , vol.355 , pp. 1949-1954
    • Lees, K.R.1    Asplund, K.2    Carolei, A.3    Davis, S.M.4    Diener, H.C.5    Kaste, M.6    Orgogozo, J.M.7    Whitehead, J.8
  • 64
    • 59049098262 scopus 로고    scopus 로고
    • An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
    • Preskorn, S. H.; Baker, B. R.; Kolluri, S.; Menniti, F. S.; Krams, M.; Landen, J. W. An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder. J. Clin. Psychopharmacol., 2008, 28, 631-637.
    • (2008) J. Clin. Psychopharmacol , vol.28 , pp. 631-637
    • Preskorn, S.H.1    Baker, B.R.2    Kolluri, S.3    Menniti, F.S.4    Krams, M.5    Landen, J.W.6
  • 65
    • 4444252518 scopus 로고    scopus 로고
    • The GLUN2B subunit-selective NMDA receptor antagonist CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain
    • New Orleans, LA
    • Sang, C. N.; Weaver, J. J.; Jinga, L.; Wouden, J.; Saltarelli, M. D. (2003) The GLUN2B subunit-selective NMDA receptor antagonist CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain in Society for Neuroscience, p 814-819, New Orleans, LA.
    • (2003) Society For Neuroscience , pp. 814-819
    • Sang, C.N.1    Weaver, J.J.2    Jinga, L.3    Wouden, J.4    Saltarelli, M.D.5
  • 66
    • 82955236070 scopus 로고    scopus 로고
    • A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory
    • Smith, J. W.; Gastambide, F.; Gilmour, G.; Dix, S.; Foss, J.; Lloyd, K.; Malik, N.; Tricklebank, M. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory. Psychopharmacology, 2011, 217, 255-269.
    • (2011) Psychopharmacology , vol.217 , pp. 255-269
    • Smith, J.W.1    Gastambide, F.2    Gilmour, G.3    Dix, S.4    Foss, J.5    Lloyd, K.6    Malik, N.7    Tricklebank, M.8
  • 67
    • 77957335007 scopus 로고    scopus 로고
    • A within-subject cognitive battery in the rat: Differential effects of NMDA receptor antagonists
    • Dix, S.; Gilmour, G.; Potts, S.; Smith, J. W.; Tricklebank, M. A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists. Psychopharmacology, 2010, 212, 227-242.
    • (2010) Psychopharmacology , vol.212 , pp. 227-242
    • Dix, S.1    Gilmour, G.2    Potts, S.3    Smith, J.W.4    Tricklebank, M.5
  • 68
    • 67649964302 scopus 로고    scopus 로고
    • Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: Implications for "NMDA antagonist modelling" of schizophrenia
    • Gilmour, G.; Pioli, E. Y.; Dix, S. L.; Smith, J. W.; Conway, M. W.; Jones, W. T.; Loomis, S.; Mason, R.; Shahabi, S.; Tricklebank, M. D. Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia. Psychopharmacology, 2009, 205, 203-216.
    • (2009) Psychopharmacology , vol.205 , pp. 203-216
    • Gilmour, G.1    Pioli, E.Y.2    Dix, S.L.3    Smith, J.W.4    Conway, M.W.5    Jones, W.T.6    Loomis, S.7    Mason, R.8    Shahabi, S.9    Tricklebank, M.D.10
  • 69
    • 0141757281 scopus 로고    scopus 로고
    • Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: Preferential involvement of the NR2B rather than NR2A subunit
    • Chaperon, F.; Muller, W.; Auberson, Y. P.; Tricklebank, M. D.; Neijt, H. C. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav. Pharmacol., 2003, 14, 477-487.
    • (2003) Behav. Pharmacol , vol.14 , pp. 477-487
    • Chaperon, F.1    Muller, W.2    Auberson, Y.P.3    Tricklebank, M.D.4    Neijt, H.C.5
  • 70
    • 62449107334 scopus 로고    scopus 로고
    • The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonisttrained rats
    • Nicholson, K. L.; Balster, R. L. The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonisttrained rats. Psychopharmacology, 2009, 203, 441-451.
    • (2009) Psychopharmacology , vol.203 , pp. 441-451
    • Nicholson, K.L.1    Balster, R.L.2
  • 71
    • 35948933040 scopus 로고    scopus 로고
    • The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101,606 in rats and rhesus monkeys
    • Nicholson, K. L.; Mansbach, R. S.; Menniti, F. S.; Balster, R. L. The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101,606 in rats and rhesus monkeys. Behav. Pharmacol., 2007, 18, 731-743.
    • (2007) Behav. Pharmacol , vol.18 , pp. 731-743
    • Nicholson, K.L.1    Mansbach, R.S.2    Menniti, F.S.3    Balster, R.L.4
  • 72
    • 33749074397 scopus 로고    scopus 로고
    • Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
    • Coyle, J. T. Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis. Cell. Mol. Neurobiol., 2006, 26, 363-382.
    • (2006) Cell. Mol. Neurobiol , vol.26 , pp. 363-382
    • Coyle, J.T.1
  • 73
    • 42749095376 scopus 로고    scopus 로고
    • Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
    • Lisman, J.; Coyle, J.; Green, R.; Javitt, D.; Benes, F.; Heckers, S.; Grace, A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci., 2008, 31, 234-242.
    • (2008) Trends Neurosci , vol.31 , pp. 234-242
    • Lisman, J.1    Coyle, J.2    Green, R.3    Javitt, D.4    Benes, F.5    Heckers, S.6    Grace, A.7
  • 74
    • 79959207825 scopus 로고    scopus 로고
    • Neurobiological background for the development of new drugs in schizophrenia
    • Lopez-Munoz, F.; Alamo, C. Neurobiological background for the development of new drugs in schizophrenia. Clin. Neuropharmacol., 2011, 34, 111-126.
    • (2011) Clin. Neuropharmacol , vol.34 , pp. 111-126
    • Lopez-Munoz, F.1    Alamo, C.2
  • 75
    • 0034811597 scopus 로고    scopus 로고
    • Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system
    • Schoepp, D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther., 2001, 299, 12-20.
    • (2001) J. Pharmacol. Exp. Ther , vol.299 , pp. 12-20
    • Schoepp, D.D.1
  • 76
    • 34447638166 scopus 로고    scopus 로고
    • Allosteric enhancers, allosteric agonists and ago-allosteric modulators: Where do they bind and how do they act?
    • Schwartz, T. W.; Holst, B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol. Sci., 2007, 28, 366-373.
    • (2007) Trends Pharmacol. Sci , vol.28 , pp. 366-373
    • Schwartz, T.W.1    Holst, B.2
  • 77
    • 79953899942 scopus 로고    scopus 로고
    • Allosteric modulation of family C G-protein-coupled receptors: From molecular insights to therapeutic perspectives
    • Urwyler, S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol. Rev., 2011, 63, 59-126.
    • (2011) Pharmacol. Rev , vol.63 , pp. 59-126
    • Urwyler, S.1
  • 78
    • 58149193205 scopus 로고    scopus 로고
    • Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders
    • Conn, J. P.; Christopoulus, A.; Lindsley, C. W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat. Rev. Drug Discov., 2009, 8, 41-54.
    • (2009) Nat. Rev. Drug Discov , vol.8 , pp. 41-54
    • Conn, J.P.1    Christopoulus, A.2    Lindsley, C.W.3
  • 79
    • 0035490101 scopus 로고    scopus 로고
    • Dynamic predictions: Oscillations and synchrony in top-down processing
    • Engel, A. K.; Fries, P.; Singer, W. Dynamic predictions: Oscillations and synchrony in top-down processing. Nat. Rev. Neurosci., 2001, 2, 704-716.
    • (2001) Nat. Rev. Neurosci , vol.2 , pp. 704-716
    • Engel, A.K.1    Fries, P.2    Singer, W.3
  • 80
    • 33745512492 scopus 로고    scopus 로고
    • Targeting information-processing deficit in schizophrenia: A novel approach to psychotherapeutic drug discovery
    • Hajos, M. Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery. Trends Pharmacol. Sci., 2006, 27, 391-398.
    • (2006) Trends Pharmacol. Sci , vol.27 , pp. 391-398
    • Hajos, M.1
  • 81
    • 54149092219 scopus 로고    scopus 로고
    • A Neural Coding Scheme Formed by the Combined Function of Gamma and Theta Oscillations
    • Lisman, J.; Buzsaki, G. A Neural Coding Scheme Formed by the Combined Function of Gamma and Theta Oscillations. Schizophr. Bull., 2008, 34, 974-980.
    • (2008) Schizophr. Bull , vol.34 , pp. 974-980
    • Lisman, J.1    Buzsaki, G.2
  • 82
    • 84866671224 scopus 로고    scopus 로고
    • Neuronal Dynamics and Neuropsychiatric Disorders: Toward a Translational Paradigm for Dysfunctional Large-Scale Networks
    • Uhlhaas, P. J.; Singer, W. Neuronal Dynamics and Neuropsychiatric Disorders: Toward a Translational Paradigm for Dysfunctional Large-Scale Networks. Neuron, 2012, 75, 963-980.
    • (2012) Neuron , vol.75 , pp. 963-980
    • Uhlhaas, P.J.1    Singer, W.2
  • 83
    • 0036305484 scopus 로고    scopus 로고
    • AMPA receptor trafficking and synaptic plasticity
    • Malinow, R.; Malenka, R. C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci., 2002, 25, 103-126.
    • (2002) Annu. Rev. Neurosci , vol.25 , pp. 103-126
    • Malinow, R.1    Malenka, R.C.2
  • 84
    • 5344241223 scopus 로고    scopus 로고
    • LTP and LTD: An Embarrassment of Riches
    • Malenka, R. C.; Bear, M. F. LTP and LTD: An Embarrassment of Riches. Neuron, 2004, 44, 5-21.
    • (2004) Neuron , vol.44 , pp. 5-21
    • Malenka, R.C.1    Bear, M.F.2
  • 85
    • 0027476024 scopus 로고
    • A synaptic model of memory: Long-term potentiation in the hippocampus
    • Bliss, T. V.; Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 1993, 361, 31-39.
    • (1993) Nature , vol.361 , pp. 31-39
    • Bliss, T.V.1    Collingridge, G.L.2
  • 86
    • 38149016966 scopus 로고    scopus 로고
    • The Cell Biology of Synaptic Plasticity: AMPA Receptor Trafficking
    • Shepherd, J. D.; Huganir, R. L. The Cell Biology of Synaptic Plasticity: AMPA Receptor Trafficking. Annu. Rev. Cell De.v Biol., 2007, 23, 613-643.
    • (2007) Annu. Rev. Cell De.v Biol , vol.23 , pp. 613-643
    • Shepherd, J.D.1    Huganir, R.L.2
  • 87
    • 33847125205 scopus 로고    scopus 로고
    • Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death
    • Liu, S. J.; Zukin, R. S. Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci., 2007, 30, 126-134.
    • (2007) Trends Neurosci , vol.30 , pp. 126-134
    • Liu, S.J.1    Zukin, R.S.2
  • 88
    • 0032192550 scopus 로고    scopus 로고
    • Neuropharmacology of AMPA and Kainate Receptors
    • Bleakman, D.; Lodge, D. Neuropharmacology of AMPA and Kainate Receptors. Neuropharmacology, 1998, 37, 1187-1204.
    • (1998) Neuropharmacology , vol.37 , pp. 1187-1204
    • Bleakman, D.1    Lodge, D.2
  • 89
    • 17844407467 scopus 로고    scopus 로고
    • Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data
    • Black, M. D. Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data. Psychopharmacology, 2005, 179, 154-163.
    • (2005) Psychopharmacology , vol.179 , pp. 154-163
    • Black, M.D.1
  • 90
    • 33748762214 scopus 로고    scopus 로고
    • Ampakines and the threefold path to cognitive enhancement
    • Lynch, G.; Gall, C. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci., 2006, 29, 554-562.
    • (2006) Trends Neurosci , vol.29 , pp. 554-562
    • Lynch, G.1    Gall, C.2
  • 91
    • 25644454403 scopus 로고    scopus 로고
    • Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors
    • Jin, R.; Clark, S.; Weeks, A. M.; Dudman, J. T.; Gouaux, E.; Partin, K. M. Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors. J. Neurosci., 2005, 25, 9027-9036.
    • (2005) J. Neurosci , vol.25 , pp. 9027-9036
    • Jin, R.1    Clark, S.2    Weeks, A.M.3    Dudman, J.T.4    Gouaux, E.5    Partin, K.M.6
  • 92
  • 93
    • 0027323942 scopus 로고
    • Mammalian ionotropic glutamate receptors
    • Wisden, W.; Seeburg, P. H. Mammalian ionotropic glutamate receptors. Curr. Opin. Neurobiol., 1993, 3, 291-298.
    • (1993) Curr. Opin. Neurobiol , vol.3 , pp. 291-298
    • Wisden, W.1    Seeburg, P.H.2
  • 94
    • 0025804443 scopus 로고
    • Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing
    • Monyer, H.; Seeburg, P. H.; Wisden, W. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron, 1991, 6, 799-810.
    • (1991) Neuron , vol.6 , pp. 799-810
    • Monyer, H.1    Seeburg, P.H.2    Wisden, W.3
  • 96
    • 66049091323 scopus 로고    scopus 로고
    • Flip and flop: A molecular determinant for AMPA receptor channel opening
    • Pei, W.; Huang, Z.; Wang, C.; Han, Y.; Park, J. S.; Niu, L. Flip and flop: a molecular determinant for AMPA receptor channel opening. Biochemistry, 2009, 48, 3767-3777.
    • (2009) Biochemistry , vol.48 , pp. 3767-3777
    • Pei, W.1    Huang, Z.2    Wang, C.3    Han, Y.4    Park, J.S.5    Niu, L.6
  • 97
    • 2342462388 scopus 로고    scopus 로고
    • Structure and Function of Glutamate Receptor Ion Channels1
    • Mayer, M. L.; Armstrong, N. Structure and Function of Glutamate Receptor Ion Channels1. Annu. Rev. Physiol., 2004, 66, 161-181.
    • (2004) Annu. Rev. Physiol , vol.66 , pp. 161-181
    • Mayer, M.L.1    Armstrong, N.2
  • 98
    • 33645321641 scopus 로고    scopus 로고
    • Glutamate receptors at atomic resolution
    • Mayer, M. L. Glutamate receptors at atomic resolution. Nature, 2006, 440, 456-462.
    • (2006) Nature , vol.440 , pp. 456-462
    • Mayer, M.L.1
  • 99
    • 72049124287 scopus 로고    scopus 로고
    • X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor
    • Sobolevsky, A. I.; Rosconi, M. P.; Gouaux, E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature, 2009, 462, 745-756.
    • (2009) Nature , vol.462 , pp. 745-756
    • Sobolevsky, A.I.1    Rosconi, M.P.2    Gouaux, E.3
  • 101
    • 0043033172 scopus 로고    scopus 로고
    • Structural basis for partial agonist action at ionotropic glutamate receptors
    • Jin, R.; Banke, T. G.; Mayer, M. L.; Traynelis, S. F.; Gouaux, E. Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci., 2003, 6, 803-810.
    • (2003) Nat Neurosci , vol.6 , pp. 803-810
    • Jin, R.1    Banke, T.G.2    Mayer, M.L.3    Traynelis, S.F.4    Gouaux, E.5
  • 102
    • 0033636314 scopus 로고    scopus 로고
    • Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core
    • Armstrong, N.; Gouaux, E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron, 2000, 28, 165-218
    • (2000) Neuron , vol.28 , pp. 165-218
    • Armstrong, N.1    Gouaux, E.2
  • 104
    • 0029862192 scopus 로고    scopus 로고
    • AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate
    • Partin, K. M.; Fleck, M. W.; Mayer, M. L. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J. Neurosci., 1996, 16, 6634-6647.
    • (1996) J. Neurosci , vol.16 , pp. 6634-6647
    • Partin, K.M.1    Fleck, M.W.2    Mayer, M.L.3
  • 105
    • 77949386630 scopus 로고    scopus 로고
    • Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors
    • Ahmed, A. H.; Oswald, R. E. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J. Med. Chem., 2010, 53, 2197-2203.
    • (2010) J. Med. Chem , vol.53 , pp. 2197-2203
    • Ahmed, A.H.1    Oswald, R.E.2
  • 106
    • 0036751341 scopus 로고    scopus 로고
    • LY404187: A novel positive allosteric modulator of AMPA receptors
    • Quirk, J. C.; Nisenbaum, E. S. LY404187: a novel positive allosteric modulator of AMPA receptors. CNS Drug Reviews, 2002, 8, 255-282.
    • (2002) CNS Drug Reviews , vol.8 , pp. 255-282
    • Quirk, J.C.1    Nisenbaum, E.S.2
  • 107
    • 0027964227 scopus 로고
    • Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants
    • Partin, K. M.; Patneau, D. K.; Mayer, M. L. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol., 1994, 46, 129-138.
    • (1994) Mol. Pharmacol , vol.46 , pp. 129-138
    • Partin, K.M.1    Patneau, D.K.2    Mayer, M.L.3
  • 108
    • 70149112131 scopus 로고    scopus 로고
    • Probing the allosteric modulator binding site of GluR2 with thiazide derivatives
    • Ptak, C. P.; Ahmed, A. H.; Oswald, R. E. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. Biochemistry, 2009, 48, 8594-8602.
    • (2009) Biochemistry , vol.48 , pp. 8594-8602
    • Ptak, C.P.1    Ahmed, A.H.2    Oswald, R.E.3
  • 109
  • 110
    • 0032708893 scopus 로고    scopus 로고
    • Piracetam in the treatment of schizophrenia: Implications for the glutamate hypothesis of schizophrenia
    • Noorbala, A. A.; Akhondzadeh, S.; Davari-Ashtiani, R.; Amini-Nooshabadi, H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. J. Clin. Pharm. Ther., 1999, 24, 369-374.
    • (1999) J. Clin. Pharm. Ther , vol.24 , pp. 369-374
    • Noorbala, A.A.1    Akhondzadeh, S.2    Davari-Ashtiani, R.3    Amini-Nooshabadi, H.4
  • 111
    • 0036667175 scopus 로고    scopus 로고
    • CX-516 Cortex pharmaceuticals
    • Danysz, W. CX-516 Cortex pharmaceuticals. Curr. Opin. Investig. Drugs., 2002, 3, 1081-1088.
    • (2002) Curr. Opin. Investig. Drugs , vol.3 , pp. 1081-1088
    • Danysz, W.1
  • 112
    • 0036773660 scopus 로고    scopus 로고
    • Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: A case series
    • Marenco, S.; Egan, M. F.; Goldberg, T. E.; Knable, M. B.; McClure, R. K.; Winterer, G.; Weinberger, D. R. Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophr. Res., 2002, 57, 221-226.
    • (2002) Schizophr. Res , vol.57 , pp. 221-226
    • Marenco, S.1    Egan, M.F.2    Goldberg, T.E.3    Knable, M.B.4    McClure, R.K.5    Winterer, G.6    Weinberger, D.R.7
  • 115
    • 0028343648 scopus 로고
    • Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
    • Monyer, H.; Burnashev, N.; Laurie, D. J.; Sakmann, B.; Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 1994, 12, 529-540.
    • (1994) Neuron , vol.12 , pp. 529-540
    • Monyer, H.1    Burnashev, N.2    Laurie, D.J.3    Sakmann, B.4    Seeburg, P.H.5
  • 117
    • 0035369112 scopus 로고    scopus 로고
    • NMDA receptor subunits: Diversity, development and disease
    • Cull-Candy, S. G.; Brickley, S.; Farrant, M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol., 2001, 11, 327-335.
    • (2001) Curr. Opin. Neurobiol , vol.11 , pp. 327-335
    • Cull-Candy, S.G.1    Brickley, S.2    Farrant, M.3
  • 119
    • 84862171078 scopus 로고    scopus 로고
    • A history of spike-timing-dependent plasticity
    • Markram, H. A history of spike-timing-dependent plasticity. Front. Synaptic Neurosci., 2011, 3, 1-24.
    • (2011) Front. Synaptic Neurosci , vol.3 , pp. 1-24
    • Markram, H.1
  • 120
    • 0023915822 scopus 로고
    • Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity
    • Cotman, C. W.; Monaghan, D. T.; Ganong, A. H. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu. Rev. Neurosci., 1988, 11, 61-80.
    • (1988) Annu. Rev. Neurosci , vol.11 , pp. 61-80
    • Cotman, C.W.1    Monaghan, D.T.2    Ganong, A.H.3
  • 121
    • 0027485836 scopus 로고
    • NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms
    • Malenka, R. C.; Nicoll, R. A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci., 1993, 16, 521-527.
    • (1993) Trends Neurosci , vol.16 , pp. 521-527
    • Malenka, R.C.1    Nicoll, R.A.2
  • 122
    • 67349136362 scopus 로고    scopus 로고
    • Role of distinct NMDA receptor subtypes at central synapses
    • Cull-Candy, S. G.; Leszkiewicz, D. N. Role of distinct NMDA receptor subtypes at central synapses. Science STKE, 2004, 16, 1-9.
    • (2004) Science STKE , vol.16 , pp. 1-9
    • Cull-Candy, S.G.1    Leszkiewicz, D.N.2
  • 123
    • 0027394506 scopus 로고
    • Interactions between the glycine and glutamate binding sites of the NMDA receptor
    • Lester, R. A.; Tong, G.; Jahr, C. E. Interactions between the glycine and glutamate binding sites of the NMDA receptor. J. Neurosci., 1993, 13, 1088-1096.
    • (1993) J. Neurosci , vol.13 , pp. 1088-1096
    • Lester, R.A.1    Tong, G.2    Jahr, C.E.3
  • 124
    • 0027526363 scopus 로고
    • Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization
    • Parsons, C. G.; Zong, X.; Lux, H. D. Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br. J. Pharmacol., 1993, 109, 213-221.
    • (1993) Br. J. Pharmacol , vol.109 , pp. 213-221
    • Parsons, C.G.1    Zong, X.2    Lux, H.D.3
  • 125
    • 56049092225 scopus 로고    scopus 로고
    • Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: The therapeutic potentials for schizophrenia
    • Yang, C. R.; Svensson, K. A. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia. Pharmacol. Ther., 2008, 120, 317-332.
    • (2008) Pharmacol. Ther , vol.120 , pp. 317-332
    • Yang, C.R.1    Svensson, K.A.2
  • 126
    • 20444391684 scopus 로고    scopus 로고
    • Glycine transporters: Essential regulators of neurotransmission
    • Eulenburg, V.; Armsen, W.; Betz, H.; Gomeza, J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci., 2005, 30, 325-333.
    • (2005) Trends Biochem. Sci , vol.30 , pp. 325-333
    • Eulenburg, V.1    Armsen, W.2    Betz, H.3    Gomeza, J.4
  • 127
    • 0028823737 scopus 로고
    • Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells
    • Priestley, T.; Laughton, P.; Myers, J.; Le Bourdelles, B.; Kerby, J.; Whiting, P. J. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol., 1995, 48, 841-848.
    • (1995) Mol. Pharmacol , vol.48 , pp. 841-848
    • Priestley, T.1    Laughton, P.2    Myers, J.3    Le Bourdelles, B.4    Kerby, J.5    Whiting, P.J.6
  • 128
    • 0028169661 scopus 로고
    • Ligand affinities at recombinant Nmethyl-D-aspartate receptors depend on subunit composition
    • Laurie, D. J.; Seeburg, P. H. Ligand affinities at recombinant Nmethyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol., 1994, 268, 335-345.
    • (1994) Eur. J. Pharmacol , vol.268 , pp. 335-345
    • Laurie, D.J.1    Seeburg, P.H.2
  • 130
    • 0025609520 scopus 로고
    • Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics
    • Waziri, R.; Baruah, S.; Hegwood, T. S.; Sherman, A. D. Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics. Neurosci. Lett., 1990, 120, 237-240.
    • (1990) Neurosci. Lett , vol.120 , pp. 237-240
    • Waziri, R.1    Baruah, S.2    Hegwood, T.S.3    Sherman, A.D.4
  • 131
    • 0027400406 scopus 로고
    • Abnormal serine-glycine metabolism in the brains of schizophrenics
    • Waziri, R.; Baruah, S.; Sherman, A. D. Abnormal serine-glycine metabolism in the brains of schizophrenics. Schizophr. Res., 1993, 8, 233-243.
    • (1993) Schizophr. Res , vol.8 , pp. 233-243
    • Waziri, R.1    Baruah, S.2    Sherman, A.D.3
  • 132
    • 21244442890 scopus 로고    scopus 로고
    • Dysfunction of glia-neuron communication in pathophysiology of schizophrenia
    • Hashimoto, K.; Shimuzu, E.; Iyo, M. Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr. Psychiatry Rev., 2005, 1, 151-163.
    • (2005) Curr. Psychiatry Rev , vol.1 , pp. 151-163
    • Hashimoto, K.1    Shimuzu, E.2    Iyo, M.3
  • 134
    • 3142737856 scopus 로고    scopus 로고
    • The NMDA receptor glycine modulatory site: A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia
    • Coyle, J. T.; Tsai, G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl), 2004, 174, 32-38.
    • (2004) Psychopharmacology (Berl) , vol.174 , pp. 32-38
    • Coyle, J.T.1    Tsai, G.2
  • 135
    • 84859106184 scopus 로고    scopus 로고
    • Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia
    • de Bartolomeis, A.; Sarappa, C.; Magara, S.; Iasevoli, F. Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. Eur. J. Pharmacol., 2012, 682, 1-11.
    • (2012) Eur. J. Pharmacol , vol.682 , pp. 1-11
    • de Bartolomeis, A.1    Sarappa, C.2    Magara, S.3    Iasevoli, F.4
  • 136
    • 0348047434 scopus 로고    scopus 로고
    • Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: A retrospective analysis
    • Heresco-Levy, U.; Javitt, D. C. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr. Res., 2004, 66, 89-96.
    • (2004) Schizophr. Res , vol.66 , pp. 89-96
    • Heresco-Levy, U.1    Javitt, D.C.2
  • 138
    • 18844441253 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
    • Diaz, P.; Bhaskara, S.; Dursun, S. M.; Deakin, B. Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results. J. Clin. Psychopharmacol., 2005, 25, 277-278.
    • (2005) J. Clin. Psychopharmacol , vol.25 , pp. 277-278
    • Diaz, P.1    Bhaskara, S.2    Dursun, S.M.3    Deakin, B.4
  • 140
    • 58349083854 scopus 로고    scopus 로고
    • Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors
    • Labrie, V.; Clapcote, S. J.; Roder, J. C. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Pharmacol. Biochem. Behav., 2009, 91, 610-620.
    • (2009) Pharmacol. Biochem. Behav , vol.91 , pp. 610-620
    • Labrie, V.1    Clapcote, S.J.2    Roder, J.C.3
  • 142
    • 0027159584 scopus 로고
    • Free D-serine, D-aspartate and D alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase
    • Hashimoto, A., Nishikawa, T., Konno, R., Niwa, A., Yasumura, Y., Oka, T. and Takahashi, K. Free D-serine, D-aspartate and D alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci. Lett., 1993, 152, 33-36.
    • (1993) Neurosci. Lett , vol.152 , pp. 33-36
    • Hashimoto, A.1    Nishikawa, T.2    Konno, R.3    Niwa, A.4    Yasumura, Y.5    Oka, T.6    Takahashi, K.7
  • 143
    • 23044465220 scopus 로고    scopus 로고
    • Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase
    • Maekawa, M.; Watanabe, M.; Yamaguchi, S.; Konno, R.; Hori, Y. Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase. Neurosci. Res., 2005, 53, 34-38.
    • (2005) Neurosci. Res , vol.53 , pp. 34-38
    • Maekawa, M.1    Watanabe, M.2    Yamaguchi, S.3    Konno, R.4    Hori, Y.5
  • 144
    • 13244260784 scopus 로고    scopus 로고
    • Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801
    • Hashimoto, A.; Yoshikawa, M.; Niwa, A.; Konno, R. Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Res., 2005, 1033, 210-215.
    • (2005) Brain Res , vol.1033 , pp. 210-215
    • Hashimoto, A.1    Yoshikawa, M.2    Niwa, A.3    Konno, R.4
  • 145
    • 67349116852 scopus 로고    scopus 로고
    • Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine
    • Hashimoto, K.; Fujita, Y.; Horio, M.; Kunitachi, S.; Iyo, M.; Ferraris, D.; Tsukamoto, T. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol. Psychiatry, 2009, 65, 1103-1106.
    • (2009) Biol. Psychiatry , vol.65 , pp. 1103-1106
    • Hashimoto, K.1    Fujita, Y.2    Horio, M.3    Kunitachi, S.4    Iyo, M.5    Ferraris, D.6    Tsukamoto, T.7
  • 146
    • 77949447469 scopus 로고    scopus 로고
    • Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
    • Tsai, G. E.; Lin, P. Y. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr. Pharm. Des., 2010, 16, 522-537.
    • (2010) Curr. Pharm. Des , vol.16 , pp. 522-537
    • Tsai, G.E.1    Lin, P.Y.2
  • 147
    • 0034898096 scopus 로고    scopus 로고
    • Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine
    • Sheinin, A.; Shavit, S.; Benveniste, M. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology, 2001, 41, 151-158.
    • (2001) Neuropharmacology , vol.41 , pp. 151-158
    • Sheinin, A.1    Shavit, S.2    Benveniste, M.3
  • 149
    • 0027213413 scopus 로고
    • Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene
    • Borowsky, B.; Mezey, E.; Hoffman, B. J. Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron, 1993, 10, 851-863.
    • (1993) Neuron , vol.10 , pp. 851-863
    • Borowsky, B.1    Mezey, E.2    Hoffman, B.J.3
  • 150
    • 19544382900 scopus 로고    scopus 로고
    • Glycine transporters: Crucial roles of pharmacological interest revealed by gene deletion
    • Aragon, C.; Lopez-Corcuera, B. Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol. Sci., 2005, 26, 283-286.
    • (2005) Trends Pharmacol. Sci , vol.26 , pp. 283-286
    • Aragon, C.1    Lopez-Corcuera, B.2
  • 151
    • 15244347525 scopus 로고    scopus 로고
    • Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain
    • Cubelos, B.; Gimenez, C.; Zafra, F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb. Cortex, 2005, 15, 448-459.
    • (2005) Cereb. Cortex , vol.15 , pp. 448-459
    • Cubelos, B.1    Gimenez, C.2    Zafra, F.3
  • 152
    • 0029014595 scopus 로고
    • Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS
    • Zafra, F.; Gomeza, J.; Olivares, L.; Aragon, C.; Gimenez, C. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur. J. Neurosci., 1995, 7, 1342-1352.
    • (1995) Eur. J. Neurosci , vol.7 , pp. 1342-1352
    • Zafra, F.1    Gomeza, J.2    Olivares, L.3    Aragon, C.4    Gimenez, C.5
  • 153
    • 0032441894 scopus 로고    scopus 로고
    • Modulation of N-methyl-D-aspartate receptor function by glycine transport
    • Bergeron, R.; Meyer, T. M.; Coyle, J. T.; Greene, R. W. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc. Natl. Acad. Sci. U S A 1998, 95, 15730-15734.
    • (1998) Proc. Natl. Acad. Sci. U S A , vol.95 , pp. 15730-15734
    • Bergeron, R.1    Meyer, T.M.2    Coyle, J.T.3    Greene, R.W.4
  • 154
    • 10744221393 scopus 로고    scopus 로고
    • Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition
    • Gomeza, J.; Hulsmann, S.; Ohno, K.; Eulenburg, V.; Szoke, K.; Richter, D.; Betz, H. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron, 2003, 40, 785-796.
    • (2003) Neuron , vol.40 , pp. 785-796
    • Gomeza, J.1    Hulsmann, S.2    Ohno, K.3    Eulenburg, V.4    Szoke, K.5    Richter, D.6    Betz, H.7
  • 156
    • 36849071470 scopus 로고    scopus 로고
    • Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
    • Lane, H. Y.; Liu, Y. C.; Huang, C. L.; Chang, Y. C.; Liau, C. H.; Perng, C. H.; Tsai, G. E. Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol Ps.ychiatry, 2008, 63, 9-12.
    • (2008) Biol Ps.ychiatry , vol.63 , pp. 9-12
    • Lane, H.Y.1    Liu, Y.C.2    Huang, C.L.3    Chang, Y.C.4    Liau, C.H.5    Perng, C.H.6    Tsai, G.E.7
  • 162
    • 57349094379 scopus 로고    scopus 로고
    • Design of potent GlyT1 inhibitors: In vitro and in vivo profiles
    • Bridges, T. M.; Williams, R.; Lindsley, C. W. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles. Curr. Opin. Mol. Ther., 2008, 10, 591-601.
    • (2008) Curr. Opin. Mol. Ther , vol.10 , pp. 591-601
    • Bridges, T.M.1    Williams, R.2    Lindsley, C.W.3
  • 164
    • 77957789035 scopus 로고    scopus 로고
    • Effect of the selective glycine reuptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates
    • Andrews, N.; Ge, J.; Walker, G.; Schipper, J.; marston, H. M. Effect of the selective glycine reuptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates. Neuropsychopharmacology, 2007, 17, S497.
    • (2007) Neuropsychopharmacology , vol.17
    • Andrews, N.1    Ge, J.2    Walker, G.3    Schipper, J.4    Marston, H.M.5
  • 167
    • 66649086928 scopus 로고    scopus 로고
    • Mechanism of differential control of NMDA receptor activity by NR2 subunits
    • Gielen, M.; Retchless, B. S.; Mony, L.; Johnson, J. W.; Paoletti, P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature, 2009, 459, 703-707.
    • (2009) Nature , vol.459 , pp. 703-707
    • Gielen, M.1    Retchless, B.S.2    Mony, L.3    Johnson, J.W.4    Paoletti, P.5
  • 168
    • 70349610345 scopus 로고    scopus 로고
    • Control of NMDA Receptor Function by the NR2 Subunit Amino-Terminal Domain
    • Yuan, H.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Traynelis, S. F. Control of NMDA Receptor Function by the NR2 Subunit Amino-Terminal Domain. J. Neurosci., 2009, 29, 12045-12058.
    • (2009) J. Neurosci , vol.29 , pp. 12045-12058
    • Yuan, H.1    Hansen, K.B.2    Vance, K.M.3    Ogden, K.K.4    Traynelis, S.F.5
  • 169
    • 81755166299 scopus 로고    scopus 로고
    • New advances in NMDA receptor pharmacology
    • Ogden, K.K.; Traynelis, S.F. New advances in NMDA receptor pharmacology. Trends Pharmacol. Sci., 2011, 32, 726-733.
    • (2011) Trends Pharmacol. Sci , vol.32 , pp. 726-733
    • Ogden, K.K.1    Traynelis, S.F.2
  • 171
    • 38849170353 scopus 로고    scopus 로고
    • Zinc inhibition of rat NR1/NR2A Nmethyl-D-aspartate receptors
    • Erreger, K.; Traynelis, S. F. Zinc inhibition of rat NR1/NR2A Nmethyl-D-aspartate receptors. J. Physiol., 2008, 586, 763-778.
    • (2008) J. Physiol , vol.586 , pp. 763-778
    • Erreger, K.1    Traynelis, S.F.2
  • 172
    • 79961020657 scopus 로고    scopus 로고
    • Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines
    • Mony, L.; Zhu, S.; Carvalho, S.; Paoletti, P. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. Embo J., 2011, 30, 3134-3146.
    • (2011) Embo J , vol.30 , pp. 3134-3146
    • Mony, L.1    Zhu, S.2    Carvalho, S.3    Paoletti, P.4
  • 173
    • 0032914455 scopus 로고    scopus 로고
    • Antagonists selective for NMDA receptors containing the GLUN2B subunit
    • Chenard, B. L.; Menniti, F. S. Antagonists selective for NMDA receptors containing the GLUN2B subunit. Curr. Pharm. Des., 1999, 5, 381-404.
    • (1999) Curr. Pharm. Des , vol.5 , pp. 381-404
    • Chenard, B.L.1    Menniti, F.S.2
  • 174
    • 0036250086 scopus 로고    scopus 로고
    • NR2B selective NMDA receptor antagonists
    • Nikam, S. S.; Meltzer, L. T. NR2B selective NMDA receptor antagonists. Curr. Pharm. Des., 2002, 8, 845-855.
    • (2002) Curr. Pharm. Des , vol.8 , pp. 845-855
    • Nikam, S.S.1    Meltzer, L.T.2
  • 175
    • 18144428396 scopus 로고    scopus 로고
    • NR2B subtype-selective NMDA receptor antagonists: 2001-2004
    • McCauley, J. A. NR2B subtype-selective NMDA receptor antagonists: 2001-2004. Expert Opin. Ther. Pat., 2005, 15 389-407.
    • (2005) Expert Opin. Ther. Pat , vol.15 , pp. 389-407
    • McCauley, J.A.1
  • 176
    • 33646594995 scopus 로고    scopus 로고
    • Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists
    • Layton, M. E.; Kelly, M. J., 3rd; Rodzinak, K. J. Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. Curr. Top. Med. Chem., 2006, 6, 697-709.
    • (2006) Curr. Top. Med. Chem , vol.6 , pp. 697-709
    • Layton, M.E.1    Kelly III, M.J.2    Rodzinak, K.J.3
  • 177
    • 78650649700 scopus 로고    scopus 로고
    • Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists
    • Beinat, C.; Banister, S.; Moussa, I.; Reynolds, A. J.; McErlean, C. S. P.; Kassiou, M. Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists. Curr. Med. Chem., 2010, 17, 4166-4190.
    • (2010) Curr. Med. Chem , vol.17 , pp. 4166-4190
    • Beinat, C.1    Banister, S.2    Moussa, I.3    Reynolds, A.J.4    McErlean, C.S.P.5    Kassiou, M.6
  • 179
    • 79952411415 scopus 로고    scopus 로고
    • Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors
    • Hansen, K. B.; Traynelis, S. F. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J. Neurosci., 2011, 31, 3650-3661.
    • (2011) J. Neurosci , vol.31 , pp. 3650-3661
    • Hansen, K.B.1    Traynelis, S.F.2
  • 182
    • 84865746076 scopus 로고    scopus 로고
    • Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
    • Monaghan, D. T.; Irvine, M. W.; Costa, B. M.; Fang, G.; Jane, D. E. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochem. Int., 2012, 61, 581-592.
    • (2012) Neurochem. Int , vol.61 , pp. 581-592
    • Monaghan, D.T.1    Irvine, M.W.2    Costa, B.M.3    Fang, G.4    Jane, D.E.5
  • 183
    • 79960417429 scopus 로고    scopus 로고
    • Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
    • Karakas, E.; Simorowski, N.; Furukawa, H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature, 2011, 475, 249-253.
    • (2011) Nature , vol.475 , pp. 249-253
    • Karakas, E.1    Simorowski, N.2    Furukawa, H.3
  • 184
    • 72449151659 scopus 로고    scopus 로고
    • Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit
    • Karakas, E.; Simorowski, N.; Furukawa, H. Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit. Embo J., 2009, 28, 3910-3920.
    • (2009) Embo J , vol.28 , pp. 3910-3920
    • Karakas, E.1    Simorowski, N.2    Furukawa, H.3
  • 188
    • 34047250333 scopus 로고    scopus 로고
    • Maintenance of superior learning and memory function in NR2B transgenic mice during ageing
    • Cao, X.; Cui, Z.; Feng, R.; Tang, Y. P.; Qin, Z.; Mei, B.; Tsien, J. Z. Maintenance of superior learning and memory function in NR2B transgenic mice during ageing. Eur. J. Neurosci., 2007, 25, 1815-1822.
    • (2007) Eur. J. Neurosci , vol.25 , pp. 1815-1822
    • Cao, X.1    Cui, Z.2    Feng, R.3    Tang, Y.P.4    Qin, Z.5    Mei, B.6    Tsien, J.Z.7
  • 190
    • 0034793826 scopus 로고    scopus 로고
    • Differential effects of enrichment on learning and memory function in NR2B transgenic mice
    • Tang, Y. P.; Wang, H.; Feng, R.; Kyin, M.; Tsien, J. Z. Differential effects of enrichment on learning and memory function in NR2B transgenic mice. Neuropharmacology, 2001, 41, 779-790.
    • (2001) Neuropharmacology , vol.41 , pp. 779-790
    • Tang, Y.P.1    Wang, H.2    Feng, R.3    Kyin, M.4    Tsien, J.Z.5
  • 191
    • 70449397522 scopus 로고    scopus 로고
    • Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats
    • Wang, D.; Cui, Z.; Zeng, Q.; Kuang, H.; Wang, L. P.; Tsien, J. Z.; Cao, X. Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats. PLoS One, 2009, 4, e7486.
    • (2009) PLoS One , vol.4
    • Wang, D.1    Cui, Z.2    Zeng, Q.3    Kuang, H.4    Wang, L.P.5    Tsien, J.Z.6    Cao, X.7
  • 194
    • 69749094446 scopus 로고    scopus 로고
    • NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses
    • Akashi, K.; Kakizaki, T.; Kamiya, H.; Fukaya, M.; Yamasaki, M.; Abe, M.; Natsume, R.; Watanabe, M.; Sakimura, K. NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J. Neurosci., 2009, 29, 10869-10882.
    • (2009) J. Neurosci , vol.29 , pp. 10869-10882
    • Akashi, K.1    Kakizaki, T.2    Kamiya, H.3    Fukaya, M.4    Yamasaki, M.5    Abe, M.6    Natsume, R.7    Watanabe, M.8    Sakimura, K.9
  • 195
    • 0036583275 scopus 로고    scopus 로고
    • A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat
    • Clayton, D. A.; Mesches, M. H.; Alvarez, E.; Bickford, P. C.; Browning, M. D. A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat. J. Neurosci., 2002, 22, 3628-3637.
    • (2002) J. Neurosci , vol.22 , pp. 3628-3637
    • Clayton, D.A.1    Mesches, M.H.2    Alvarez, E.3    Bickford, P.C.4    Browning, M.D.5
  • 196
    • 1242351945 scopus 로고    scopus 로고
    • The NMDA receptor NR2B subunit: A valid therapeutic target for multiple CNS pathologies
    • Chazot, P. L. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr. Med. Chem., 2004, 11, 389-396.
    • (2004) Curr. Med. Chem , vol.11 , pp. 389-396
    • Chazot, P.L.1
  • 197
    • 30844451008 scopus 로고    scopus 로고
    • Glutamate-based therapeutic approaches: NR2B receptor antagonists
    • Gogas, K. R. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin. Pharmacol., 2006, 6, 68-74.
    • (2006) Curr Opin. Pharmacol , vol.6 , pp. 68-74
    • Gogas, K.R.1
  • 198
    • 70350324907 scopus 로고    scopus 로고
    • Allosteric modulators of NR2B-containing NMDA receptors: Molecular. mechanisms and therapeutic potential
    • Mony, L.; Kew, J. N.; Gunthorpe, M. J.; Paoletti, P. Allosteric modulators of NR2B-containing NMDA receptors: molecular. mechanisms and therapeutic potential. Br. J. Pharmacol., 2009, 157, 1301-1317.
    • (2009) Br. J. Pharmacol , vol.157 , pp. 1301-1317
    • Mony, L.1    Kew, J.N.2    Gunthorpe, M.J.3    Paoletti, P.4
  • 199
    • 35948933040 scopus 로고    scopus 로고
    • The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101606 in rats and rhesus monkeys
    • Nicholson, K. L.; Mansbach, R. S.; Menniti, F. S.; Balster, R. L. The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101606 in rats and rhesus monkeys. Behav. Pharmacol., 2007, 18, 731-743.
    • (2007) Behav. Pharmacol , vol.18 , pp. 731-743
    • Nicholson, K.L.1    Mansbach, R.S.2    Menniti, F.S.3    Balster, R.L.4
  • 200
    • 0141757281 scopus 로고    scopus 로고
    • Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: Preferential involvement of the NR2B rather than NR2A subunit
    • Chaperon, F.; Muller, W.; Auberson, Y. P.; Tricklebank, M. D.; Neijt, H. C. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav. Pharmacol., 2003, 14, 477-487.
    • (2003) Behav. Pharmacol , vol.14 , pp. 477-487
    • Chaperon, F.1    Muller, W.2    Auberson, Y.P.3    Tricklebank, M.D.4    Neijt, H.C.5
  • 201
    • 0029100602 scopus 로고
    • (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-D-aspartate responses
    • Chenard, B. L.; Bordner, J.; Butler, T. W.; Chambers, L. K.; Collins, M. A.; De Costa, D. L.; Ducat, M. F.; Dumont, M. L.; Fox, C. B.; Mena, E. E. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem., 1995, 38, 3138-3145.
    • (1995) J. Med. Chem , vol.38 , pp. 3138-3145
    • Chenard, B.L.1    Bordner, J.2    Butler, T.W.3    Chambers, L.K.4    Collins, M.A.5    de Costa, D.L.6    Ducat, M.F.7    Dumont, M.L.8    Fox, C.B.9    Mena, E.E.10
  • 202
    • 0030839993 scopus 로고    scopus 로고
    • CP-101,606, a potent neuroprotectant selective for forebrain neurons-I. Evidence for efficacy in models of focal cerebral ischemia
    • Menniti, F.; Chenard, B.; Collins, M.; Ducat, M.; Shalaby, I.; White, F. CP-101,606, a potent neuroprotectant selective for forebrain neurons-I. Evidence for efficacy in models of focal cerebral ischemia. Eur. J. Pharmacol., 1997, 331, 117-126.
    • (1997) Eur. J. Pharmacol , vol.331 , pp. 117-126
    • Menniti, F.1    Chenard, B.2    Collins, M.3    Ducat, M.4    Shalaby, I.5    White, F.6
  • 204
    • 0033392424 scopus 로고    scopus 로고
    • A double-blind, placebocontrolled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury
    • Merchant, R. E.; Bullock, M. R.; Carmack, C. A.; Shah, A. K.; Wilner, K. D.; Ko, G.; Williams, S. A. A double-blind, placebocontrolled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. Ann. N Y Acad. Sci., 1999, 890, 42-50.
    • (1999) Ann. N Y Acad. Sci , vol.890 , pp. 42-50
    • Merchant, R.E.1    Bullock, M.R.2    Carmack, C.A.3    Shah, A.K.4    Wilner, K.D.5    Ko, G.6    Williams, S.A.7
  • 205
    • 59049098262 scopus 로고    scopus 로고
    • An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder
    • Preskorn, S. H.; Baker, B.; Kolluri, S.; Menniti, F. S.; Krams, M.; Landen, J. W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder. J. Clin. Psychopharmacol., 2008, 28, 631-637.
    • (2008) J. Clin. Psychopharmacol , vol.28 , pp. 631-637
    • Preskorn, S.H.1    Baker, B.2    Kolluri, S.3    Menniti, F.S.4    Krams, M.5    Landen, J.W.6
  • 207
    • 33846194535 scopus 로고    scopus 로고
    • Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis
    • Li, D.; He, L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet. Med., 2007, 9, 4-8.
    • (2007) Genet. Med , vol.9 , pp. 4-8
    • Li, D.1    He, L.2
  • 208
    • 9244224117 scopus 로고    scopus 로고
    • Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors
    • Horak, M.; Vlcek, K.; Petrovic, M.; Chodounska, H.; Vyklicky, L. Jr. Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors. J. Neurosci., 2004 24, 10318-10325.
    • (2004) J. Neurosci , vol.24 , pp. 10318-10325
    • Horak, M.1    Vlcek, K.2    Petrovic, M.3    Chodounska, H.4    Vyklicky Jr., L.5
  • 210
    • 0028867740 scopus 로고
    • Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+
    • Paoletti, P.; Neyton, J.; Ascher, P. Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+. Neuron, 1995, 15, 1109-1120.
    • (1995) Neuron , vol.15 , pp. 1109-1120
    • Paoletti, P.1    Neyton, J.2    Ascher, P.3
  • 211
    • 0028340993 scopus 로고
    • Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits
    • Williams, K.; Zappia, A.M.; Pritchett, D.B.; Shen, Y.M.; Molinoff, P.B. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol., 1994, 45, 803-809.
    • (1994) Mol. Pharmacol , vol.45 , pp. 803-809
    • Williams, K.1    Zappia, A.M.2    Pritchett, D.B.3    Shen, Y.M.4    Molinoff, P.B.5
  • 212
    • 1642452716 scopus 로고    scopus 로고
    • A molecular mechanism for stabilization of learning-induced synaptic modifications
    • Quinlan, E. M.; Lebel, D.; Brosh, I.; Barkai, E. A molecular mechanism for stabilization of learning-induced synaptic modifications. Neuron, 2004, 41, 185-192.
    • (2004) Neuron , vol.41 , pp. 185-192
    • Quinlan, E.M.1    Lebel, D.2    Brosh, I.3    Barkai, E.4
  • 213
    • 77953951999 scopus 로고    scopus 로고
    • Metaplasticity at single glutamatergic synapses
    • Lee, M. C.; Yasuda, R.; Ehlers, M. D. Metaplasticity at single glutamatergic synapses. Neuron, 2010, 66, 859-870.
    • (2010) Neuron , vol.66 , pp. 859-870
    • Lee, M.C.1    Yasuda, R.2    Ehlers, M.D.3
  • 214
    • 77949420265 scopus 로고    scopus 로고
    • Promoting neurological recovery of function via metaplasticity
    • Cho, K. K.; Bear, M. F. Promoting neurological recovery of function via metaplasticity. Future Neurol., 2010, 5, 21-26.
    • (2010) Future Neurol , vol.5 , pp. 21-26
    • Cho, K.K.1    Bear, M.F.2
  • 216
    • 79953199424 scopus 로고    scopus 로고
    • Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses
    • Rauner, C.; Kohr, G. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses. J. Biol. Chem. 2011, 286, 7558-7566.
    • (2011) J. Biol. Chem , vol.286 , pp. 7558-7566
    • Rauner, C.1    Kohr, G.2
  • 217
    • 17444426068 scopus 로고    scopus 로고
    • Modulation of triheteromeric NMDA receptors by N-terminal domain ligands
    • Hatton, C.J.; Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron., 2005, 46(2), 261-274.
    • (2005) Neuron , vol.46 , Issue.2 , pp. 261-274
    • Hatton, C.J.1    Paoletti, P.2
  • 219
    • 84856120944 scopus 로고    scopus 로고
    • From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment
    • Moghaddam, B.; Javitt, D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology, 2012, 37, 4-15.
    • (2012) Neuropsychopharmacology , vol.37 , pp. 4-15
    • Moghaddam, B.1    Javitt, D.2
  • 220
    • 58149119377 scopus 로고    scopus 로고
    • Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
    • Conn, P. J.; Lindsley, C. W.; Jones, C. K. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci., 2009, 30, 25-31.
    • (2009) Trends Pharmacol. Sci , vol.30 , pp. 25-31
    • Conn, P.J.1    Lindsley, C.W.2    Jones, C.K.3
  • 221
    • 84857375139 scopus 로고    scopus 로고
    • Allosteric modulation of seven transmembrane spanning receptors: Theory, practice, and opportunities for central nervous system drug discovery
    • Melancon, B. J.; Hopkins, C. R.; Wood, M. R.; Emmitte, K. A.; Niswender, C. M.; Christopoulos, A.; Conn, P. J.; Lindsley, C. W. Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. J. Med. Chem., 2012, 55, 1445-1464.
    • (2012) J. Med. Chem , vol.55 , pp. 1445-1464
    • Melancon, B.J.1    Hopkins, C.R.2    Wood, M.R.3    Emmitte, K.A.4    Niswender, C.M.5    Christopoulos, A.6    Conn, P.J.7    Lindsley, C.W.8
  • 222
    • 53449093828 scopus 로고    scopus 로고
    • G-protein-coupled receptors: From classical modes of modulation to allosteric mechanisms
    • Bridges, T. M.; Lindsley, C. W. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. ACS Chem. Biol., 2008, 3, 530-541.
    • (2008) ACS Chem. Biol , vol.3 , pp. 530-541
    • Bridges, T.M.1    Lindsley, C.W.2
  • 223
    • 42149181885 scopus 로고    scopus 로고
    • Structural diversity of G proteincoupled receptors and significance for drug discovery
    • Lagerstrom, M. C.; Schioth, H. B. Structural diversity of G proteincoupled receptors and significance for drug discovery. Nat. Rev. Drug Discov., 2008, 7, 339-357.
    • (2008) Nat. Rev. Drug Discov , vol.7 , pp. 339-357
    • Lagerstrom, M.C.1    Schioth, H.B.2
  • 224
    • 84863255255 scopus 로고    scopus 로고
    • Structure and ligand recognition of class C GPCRs
    • Chun, L.; Zhang, W. H.; Liu, J. F. Structure and ligand recognition of class C GPCRs. Acta Pharmacol. Sin., 2012, 33, 312-323.
    • (2012) Acta Pharmacol. Sin , vol.33 , pp. 312-323
    • Chun, L.1    Zhang, W.H.2    Liu, J.F.3
  • 225
    • 0036258990 scopus 로고    scopus 로고
    • G protein-coupled receptor allosterism and complexing
    • Christopoulos, A.; Kenakin, T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev., 2002, 54, 323-374.
    • (2002) Pharmacol. Rev , vol.54 , pp. 323-374
    • Christopoulos, A.1    Kenakin, T.2
  • 226
    • 69649097791 scopus 로고    scopus 로고
    • 7TM receptor allostery: Putting numbers to shapeshifting proteins
    • Kenakin, T. P. 7TM receptor allostery: putting numbers to shapeshifting proteins. Trends Pharmacol. Sci., 2009, 30, 460-469.
    • (2009) Trends Pharmacol. Sci , vol.30 , pp. 460-469
    • Kenakin, T.P.1
  • 227
    • 33747181100 scopus 로고    scopus 로고
    • Allosteric agonists of 7TM receptors: Expanding the pharmacological toolbox
    • Langmead, C. J.; Christopoulos, A. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol. Sci., 2006, 27, 475-481.
    • (2006) Trends Pharmacol. Sci , vol.27 , pp. 475-481
    • Langmead, C.J.1    Christopoulos, A.2
  • 229
    • 44949181722 scopus 로고    scopus 로고
    • Allosteric modulation of kinases and GPCRs: Design principles and structural diversity
    • Lewis, J. A.; Lebois, E. P.; Lindsley, C. W. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Curr. Opin. Chem. Biol., 2008, 12, 269-280.
    • (2008) Curr. Opin. Chem. Biol , vol.12 , pp. 269-280
    • Lewis, J.A.1    Lebois, E.P.2    Lindsley, C.W.3
  • 230
    • 0036490942 scopus 로고    scopus 로고
    • Allosteric binding sites on cell surface receptors: Novel targets for drug discovery
    • Christopoulos, A. Allosteric binding sites on cell surface receptors: novel targets for drug discovery. Nat. Rev. Drug Discov. 2002, 1, 198-210.
    • (2002) Nat. Rev. Drug Discov , vol.1 , pp. 198-210
    • Christopoulos, A.1
  • 231
    • 77949516412 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors: Physiology, pharmacology, and disease
    • Niswender, C. M.; Conn, P. J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol., 2010, 50, 295-322.
    • (2010) Annu. Rev. Pharmacol. Toxicol , vol.50 , pp. 295-322
    • Niswender, C.M.1    Conn, P.J.2
  • 232
    • 78649909134 scopus 로고    scopus 로고
    • An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs
    • Rocheville, M.; Garland, S.L. An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs. Drug Discov. Today Technol., 2010, 7, e87-e94.
    • (2010) Drug Discov. Today Technol , vol.7
    • Rocheville, M.1    Garland, S.L.2
  • 233
    • 79955710801 scopus 로고    scopus 로고
    • Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder
    • Frank, R. A. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS One, 2011, 6, e19011.
    • (2011) PLoS One , vol.6
    • Frank, R.A.1
  • 234
    • 84858651719 scopus 로고    scopus 로고
    • Deleterious GRM1mutations n schizophrenia
    • Ayoub, M. A. Deleterious GRM1mutations n schizophrenia. PLoS One, 2012, 7, e32849.
    • (2012) PLoS One , vol.7
    • Ayoub, M.A.1
  • 235
    • 80051740508 scopus 로고    scopus 로고
    • Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu(1))
    • Owen, D. R. Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu(1)). ACS Chem. Neurosci., 2011, 2, 394-401.
    • (2011) ACS Chem. Neurosci , vol.2 , pp. 394-401
    • Owen, D.R.1
  • 236
    • 24644520313 scopus 로고    scopus 로고
    • Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5)
    • Williams, D. L., Jr.; Lindsley, C. W. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5). Curr. Top. Med. Chem., 2005, 5, 825-846.
    • (2005) Curr. Top. Med. Chem , vol.5 , pp. 825-846
    • Williams Jr., D.L.1    Lindsley, C.W.2
  • 237
    • 80051728277 scopus 로고    scopus 로고
    • Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu(5))
    • Stauffer, S. R. Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu(5)). ACS Chem. Neurosci., 2011, 2, 450-470.
    • (2011) ACS Chem. Neurosci , vol.2 , pp. 450-470
    • Stauffer, S.R.1
  • 242
    • 27744558560 scopus 로고    scopus 로고
    • Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes
    • Zhang, Y.; Rodriguez, A. L.; Conn, P. J. Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes. J. Pharmacol. Exp. Ther., 2005, 315, 1212-1219.
    • (2005) J. Pharmacol. Exp. Ther , vol.315 , pp. 1212-1219
    • Zhang, Y.1    Rodriguez, A.L.2    Conn, P.J.3
  • 243
    • 47149106805 scopus 로고    scopus 로고
    • Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold
    • Sharma, S.; Rodriguez, A. L.; Conn, P. J.; Lindsley, C. W. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold. Bioorg. Med. Chem. Lett., 2008, 18, 4098-4101.
    • (2008) Bioorg. Med. Chem. Lett , vol.18 , pp. 4098-4101
    • Sharma, S.1    Rodriguez, A.L.2    Conn, P.J.3    Lindsley, C.W.4
  • 244
    • 79953213637 scopus 로고    scopus 로고
    • Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology
    • Wood, M. R.; Hopkins, C. R.; Brogan, J. T.; Conn, P. J.; Lindsley, C. W. Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry, 2011, 50, 2403-2410.
    • (2011) Biochemistry , vol.50 , pp. 2403-2410
    • Wood, M.R.1    Hopkins, C.R.2    Brogan, J.T.3    Conn, P.J.4    Lindsley, C.W.5
  • 246
    • 0032575715 scopus 로고    scopus 로고
    • Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
    • Moghaddam, B.; Adams, B. W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science, 1998, 281, 1349-1352.
    • (1998) Science , vol.281 , pp. 1349-1352
    • Moghaddam, B.1    Adams, B.W.2
  • 248
    • 20944439080 scopus 로고    scopus 로고
    • Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
    • Krystal, J. H.; Abi-Saab, W.; Perry, E.; D'Souza, D. C.; Liu, N.; Gueorguieva, R.; McDougall, L.; Hunsberger, T.; Belger, A.; Levine, L.; Breier, A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology, 2005, 179, 303-309.
    • (2005) Psychopharmacology , vol.179 , pp. 303-309
    • Krystal, J.H.1    Abi-Saab, W.2    Perry, E.3    D'Souza, D.C.4    Liu, N.5    Gueorguieva, R.6    McDougall, L.7    Hunsberger, T.8    Belger, A.9    Levine, L.10    Breier, A.11
  • 250
    • 80051770211 scopus 로고    scopus 로고
    • Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators
    • Sheffler, D. J.; Pinkerton, A. B.; Dahl, R.; Markou, A.; Cosford, N. D. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators. ACS Chem. Neurosci., 2011, 2, 382-393.
    • (2011) ACS Chem. Neurosci , vol.2 , pp. 382-393
    • Sheffler, D.J.1    Pinkerton, A.B.2    Dahl, R.3    Markou, A.4    Cosford, N.D.5
  • 251
    • 0034029845 scopus 로고    scopus 로고
    • Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
    • Green, M. F.; Kern, R. S.; Braff, D. L.; Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff? Schizophr. Bull., 2000, 26, 119-136.
    • (2000) Schizophr. Bull , vol.26 , pp. 119-136
    • Green, M.F.1    Kern, R.S.2    Braff, D.L.3    Mintz, J.4
  • 252
    • 80052514046 scopus 로고    scopus 로고
    • The NIMH-CATIE Schizophrenia Study: What Did We Learn?
    • Lieberman, J. A.; Stroup, T. S. The NIMH-CATIE Schizophrenia Study: What Did We Learn? Am. J. Psychiatry, 2011, 168, 770-775.
    • (2011) Am. J. Psychiatry , vol.168 , pp. 770-775
    • Lieberman, J.A.1    Stroup, T.S.2
  • 253
    • 33749321169 scopus 로고    scopus 로고
    • Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
    • Jones, P. B.; Barnes, T. R.; Davies, L.; Dunn, G.; Lloyd, H.; Hayhurst, K. P.; Murray, R. M.; Markwick, A.; Lewis, S. W. Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch. Gen. Psychiatry, 2006, 63, 1079-1087.
    • (2006) Arch. Gen. Psychiatry , vol.63 , pp. 1079-1087
    • Jones, P.B.1    Barnes, T.R.2    Davies, L.3    Dunn, G.4    Lloyd, H.5    Hayhurst, K.P.6    Murray, R.M.7    Markwick, A.8    Lewis, S.W.9
  • 254
    • 33644994132 scopus 로고    scopus 로고
    • Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of headto-head comparison studies of second-generation antipsychotics
    • Heres, S.; Davis, J.; Maino, K.; Jetzinger, E.; Kissling, W.; Leucht, S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of headto-head comparison studies of second-generation antipsychotics. Am. J. Psychiatry, 2006, 163, 185-194.
    • (2006) Am. J. Psychiatry , vol.163 , pp. 185-194
    • Heres, S.1    Davis, J.2    Maino, K.3    Jetzinger, E.4    Kissling, W.5    Leucht, S.6
  • 255
    • 81755184126 scopus 로고    scopus 로고
    • Allo-network drugs: Harnessing allostery in cellular networks
    • Nussinov, R.; Tsai, C. J.; Csermely, P. Allo-network drugs: harnessing allostery in cellular networks. Trends Pharmacol. Sci., 2011, 32, 686-693.
    • (2011) Trends Pharmacol. Sci , vol.32 , pp. 686-693
    • Nussinov, R.1    Tsai, C.J.2    Csermely, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.